Stockscreener 앱 받기
12.29
11.26%
-1.56
시간 외 거래:
12.40
0.11
+0.90%
전일 마감가:
$13.85
열려 있는:
$13.62
하루 거래량:
103.52K
Relative Volume:
1.96
시가총액:
$86.31M
수익:
$100.44M
순이익/손실:
$-133.16M
주가수익비율:
-0.4771
EPS:
-25.76
순현금흐름:
$-94.85M
1주 성능:
-19.20%
1개월 성능:
-14.71%
6개월 성능:
+57.16%
1년 성능:
+5.67%
1일 변동 폭
$12.13
$13.71
1주일 범위
$12.13
$15.43
52주 변동 폭
$5.005
$18.70
아타라 Stock (ATRA) Company Profile
명칭
Atara Biotherapeutics Inc
전화
805-623-4211
주소
1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA
ATRA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ATRA
Atara Biotherapeutics Inc
|
12.29 | 97.27M | 100.44M | -133.16M | -94.85M | -25.76 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -906.14M | -6.1812 |
아타라 Stock (ATRA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-11-09 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2023-11-09 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2023-11-09 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2022-07-20 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2022-07-13 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-07-13 | 다운그레이드 | Stifel | Buy → Hold |
| 2022-05-10 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-05-13 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2020-12-09 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-12-08 | 재확인 | H.C. Wainwright | Buy |
| 2020-11-10 | 재확인 | H.C. Wainwright | Buy |
| 2020-06-30 | 개시 | Evercore ISI | Outperform |
| 2020-06-15 | 개시 | H.C. Wainwright | Buy |
| 2020-04-23 | 업그레이드 | Citigroup | Neutral → Buy |
| 2019-11-08 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2019-09-27 | 다운그레이드 | Goldman | Neutral → Sell |
| 2019-09-16 | 다운그레이드 | Jefferies | Buy → Hold |
| 2019-06-04 | 업그레이드 | Citigroup | Sell → Neutral |
| 2019-05-30 | 개시 | ROTH Capital | Buy |
| 2019-05-23 | 개시 | Stifel | Buy |
| 2019-01-23 | 개시 | Mizuho | Buy |
| 2018-04-10 | 개시 | JP Morgan | Overweight |
| 2018-03-16 | 개시 | Guggenheim | Neutral |
| 2018-03-05 | 재확인 | Jefferies | Buy |
| 2018-02-28 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2018-02-15 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2018-01-03 | 업그레이드 | Citigroup | Sell → Neutral |
| 2017-10-06 | 재개 | Goldman | Neutral |
모두보기
아타라 주식(ATRA)의 최신 뉴스
Pierre Fabre takes over tabelecleucel BLA from Atara Biotherapeutics By Investing.com - Investing.com Australia
How Atara Biotherapeutics Inc. (AT20) stock performs during market turbulenceDividend Hike & Stepwise Trade Execution Plans - newser.com
Can Atara Biotherapeutics Inc. stock deliver sustainable ROEMarket Performance Report & Real-Time Buy Zone Alerts - newser.com
Will Atara Biotherapeutics Inc. (AT20) stock sustain uptrend momentumEarnings Risk Report & Safe Entry Zone Identification - newser.com
Atara Biotherapeutics (ATRA) Transfers Key FDA Application to Pi - GuruFocus
Pierre Fabre takes over tabelecleucel BLA from Atara Biotherapeutics - Investing.com
Atara (NASDAQ: ATRA) transfers tabelecleucel BLA to Pierre Fabre; PDUFA Jan 10, 2026 - Stock Titan
Can machine learning forecast Atara Biotherapeutics Inc. recoveryJuly 2025 Institutional & Real-Time Stock Movement Alerts - newser.com
Will Atara Biotherapeutics Inc. stock attract ESG investorsJuly 2025 Reactions & Short-Term High Return Strategies - newser.com
Is Atara Biotherapeutics Inc. (AT20) stock trading at attractive multiplesQuarterly Trade Report & Step-by-Step Swing Trade Plans - newser.com
Is Atara Biotherapeutics Inc. (AT20) stock nearing a technical breakoutProfit Target & Fast Exit/Entry Strategy Plans - newser.com
How to recover losses in Atara Biotherapeutics Inc. stockDay Trade & Weekly Breakout Watchlists - newser.com
Will Atara Biotherapeutics Inc. (AT20) stock beat value stocks2025 Buyback Activity & Fast Gain Stock Trading Tips - newser.com
Live market analysis of Atara Biotherapeutics Inc.Weekly Trade Summary & Detailed Earnings Play Strategies - newser.com
Will Atara Biotherapeutics Inc. stock maintain growth storyQuarterly Profit Summary & Weekly Top Performers Watchlists - newser.com
Will a bounce in Atara Biotherapeutics Inc. offer an exitWall Street Watch & Expert Verified Stock Movement Alerts - newser.com
How robust is Atara Biotherapeutics Inc. (AT20) stock financial positionJuly 2025 Weekly Recap & Reliable Intraday Trade Plans - newser.com
Custom strategy builders for tracking Atara Biotherapeutics Inc.Trade Analysis Report & Fast Gain Stock Trading Tips - newser.com
How hedge fund analytics apply to Atara Biotherapeutics Inc. stockNew Guidance & Verified Momentum Stock Watchlist - newser.com
Is Atara Biotherapeutics Inc. stock supported by strong fundamentals2025 Buyback Activity & Entry Point Confirmation Alerts - newser.com
Is Atara Biotherapeutics Inc. forming a bottoming baseMarket Trend Review & Reliable Volume Spike Alerts - newser.com
Institutional scanner results for Atara Biotherapeutics Inc.July 2025 Outlook & Technical Pattern Based Buy Signals - newser.com
Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
5 Under-the-Radar Biotech Stocks That Could Soar in 2026 - Barchart.com
아타라 (ATRA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
0.86%
자본화:
|
볼륨(24시간):